Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04593485
What this trial is testing

Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract

Who this might be right for
Malignant Melanoma
Fudan University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05229497
What this trial is testing

A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 154
Testing effectiveness (Phase 2)UnknownNCT03619824
What this trial is testing

PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT05287113
What this trial is testing

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Incyte Biosciences International Sàrl 176
Large-scale testing (Phase 3)Looking for participantsNCT05340491
What this trial is testing

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 212
Testing effectiveness (Phase 2)Study completedNCT03222076
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer

Who this might be right for
Hepatocellular CarcinomaResectable Hepatocellular Carcinoma
M.D. Anderson Cancer Center 30
Not applicableLooking for participantsNCT06693440
What this trial is testing

The Immune Assessment of PD-1 Antibody Therapy in Tumor

Who this might be right for
Efficacy, TeamAdverse Event
Quanli Gao 3,000
Testing effectiveness (Phase 2)UnknownNCT05174325
What this trial is testing

Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)UnknownNCT04947826
What this trial is testing

Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Shanghai Zhongshan Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05354700
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Shanghai Henlius Biotech 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04516616
What this trial is testing

Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmUterine Cervical CancerCervical Cancer
Huazhong University of Science and Technology 85
Testing effectiveness (Phase 2)UnknownNCT04004234
What this trial is testing

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Who this might be right for
Biliary Tract Cancer (BTC)
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03711058
What this trial is testing

Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer

Who this might be right for
Unresectable or Metastatic Microsatellite Stable (MSS) Solid TumorMicrosatellite Stable (MSS) Colon Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746961
What this trial is testing

Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
The First Affiliated Hospital of Zhengzhou University 49
Early research (Phase 1)Ended earlyNCT03716596
What this trial is testing

SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 8
Testing effectiveness (Phase 2)UnknownNCT03346642
What this trial is testing

Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs

Who this might be right for
Primary Mediastinal Large B-cell Lymphoma
Chinese PLA General Hospital 30
Early research (Phase 1)Looking for participantsNCT05079282
What this trial is testing

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Who this might be right for
Relapsed or Refractory T Cell Lymphoma
Ono Pharmaceutical Co., Ltd. 217
Testing effectiveness (Phase 2)Active Not RecruitingNCT06812260
What this trial is testing

A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Shanghai Henlius Biotech 26
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Large-scale testing (Phase 3)Active Not RecruitingNCT05800015
What this trial is testing

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Regeneron Pharmaceuticals 160
Next Page